Page last updated: 2024-11-06
zonisamide and Injury, Ischemia-Reperfusion
zonisamide has been researched along with Injury, Ischemia-Reperfusion in 1 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "Zonisamide (ZNS) has shown anti-apoptosis effects in recent studies." | 5.62 | Neuroprotective effects of zonisamide on cerebral ischemia injury via inhibition of neuronal apoptosis. ( Chen, R; Chen, Y; He, J; He, W; Xie, Y; Yang, Y; Zhang, X, 2021) |
| "Zonisamide (ZNS) has shown anti-apoptosis effects in recent studies." | 1.62 | Neuroprotective effects of zonisamide on cerebral ischemia injury via inhibition of neuronal apoptosis. ( Chen, R; Chen, Y; He, J; He, W; Xie, Y; Yang, Y; Zhang, X, 2021) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| He, J | 1 |
| Zhang, X | 1 |
| He, W | 1 |
| Xie, Y | 1 |
| Chen, Y | 1 |
| Yang, Y | 1 |
| Chen, R | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Neuroprotective Effect of Dapsone in Patients With Aneurysmal Subarachnoid Hemorrhage: Prospective, Randomized, Double-Blinded, Placebo-Controlled, Clinical Trial[NCT05131295] | Phase 3 | 49 participants (Actual) | Interventional | 2007-09-05 | Completed |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for zonisamide and Injury, Ischemia-Reperfusion